Shaanxi Panlong Pharmaceutical Group (SZSE:002864) ROCE % : 8.51% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Shaanxi Panlong Pharmaceutical Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shaanxi Panlong Pharmaceutical Group's annualized ROCE % for the quarter that ended in Mar. 2024 was 8.51%.

Shaanxi Panlong Pharmaceutical Group ROCE % Historical Data

The historical data trend for Shaanxi Panlong Pharmaceutical Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shaanxi Panlong Pharmaceutical Group ROCE % Chart

Shaanxi Panlong Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

12.26

12.84

13.13

13.86

10.13

Shaanxi Panlong Pharmaceutical Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															9.48	12.32	9.94	8.08	8.51

Shaanxi Panlong Pharmaceutical Group ROCE % Calculation

Shaanxi Panlong Pharmaceutical Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	135.36	/	( ( (1930.787 - 902.678)	+	(2125.02 - 480.407) )	/ 2 )
	=	135.36	/	( (1028.109	+	1644.613)	/ 2 )
	=	135.36	/	1336.361
	=	10.13 %

Shaanxi Panlong Pharmaceutical Group's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	145.756	/	( ( (2125.02 - 480.407)	+	(2189.4 - 409.175) )	/ 2 )
	=	145.756	/	( ( 1644.613	+	1780.225 )	/ 2 )
	=	145.756	/	1712.419
	=	8.51 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Shaanxi Panlong Pharmaceutical Group (SZSE:002864) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shaanxi Panlong Pharmaceutical Group ROCE % Related Terms

Thank you for viewing the detailed overview of Shaanxi Panlong Pharmaceutical Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shaanxi Panlong Pharmaceutical Group (SZSE:002864) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shaanxi Panlong Pharmaceutical Group Ltd (SZSE:002864) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

2801 Baliu 2nd Road, Modern Textile Ind Park Baqiao, Xian, CHN, 710025

Website

http://www.pljt.com

Shaanxi Panlong Pharmaceutical Group Ltd operates as a pharmaceuticals company. It manufactures and markets drugs for the treatment of traumatology, cardiovascular and cerebrovascular, respiratory, pediatrics, and hepatobiliary.

Executives

Zhang De Zhu	Directors, executives
Liu Zhao	Supervisors
Jian Bao Liang	Supervisors
Zhang Zhi Hong	Directors, executives
Zhang Shui Ping	Director
Wu Jie	Directors, Directors, and Executives
Zhu Feng Ming	Executives
Zhu Wen Feng	Director
Xie Xiao Feng	Director
Xie Xiao Lin	Directors, executives

Shaanxi Panlong Pharmaceutical Group (SZSE:002864) Headlines

No Headlines